LUGPA Policy Update - CMS Announces Negotiated Drug Prices under the Inflation Reduction ActOn August 15th, CMS released the negotiated prices for ten drugs selected for price negotiations under the Inflation Reduction Act (IRA). These drugs, which are among the most costly and widely prescribed within the Medicare program, treat conditions such as heart disease, diabetes, and cancer. In 2023, CMS identified these drugs for negotiation under the IRA, which was signed into law in August 2022 with the goals of expanding Medicare benefits, reducing drug costs, and improving the sustainability of the Medicare program. Previously, these drugs represented a significant portion of Medicare Part D expenditures, leading to substantial out-of-pocket patient costs. The negotiated prices aim to reduce costs for Medicare beneficiaries. For example, the price of dapagliflozin, a drug used to treat type 2 diabetes, heart failure, and chronic kidney disease, will decrease by 68%, from $556 to $179. Similar reductions have been negotiated for other medications, with price decreases ranging from 38% to 79%. The negotiated prices will take effect on January 1, 2026. The price reductions are projected to save Medicare $6 billion in the first year. List of Drugs and Their Negotiated Prices:
CMS plans to select up to 15 additional drugs for negotiation annually starting in 2027, with further expansions in subsequent years. This approach is intended to address the cost and accessibility of essential medications within Medicare. The CMS announcement represents a significant development in the ongoing efforts to manage drug costs within Medicare. LUGPA will continue to monitor these changes and assess their impact on urology practices and patient care. A Fact Sheet on the ten drugs is available here: https://www.cms.gov/files/document/fact-sheet-negotiated-prices-initial-price-applicability-year-2026.pdf. |
Upcoming Events
Wed Sep 18, 2024A Framework to Manage a New Disease State: High-Risk Biochemically Recurrent Prostate Cancer Category: Online Events |
Mon Sep 23, 2024CME: Finding the Treatments That Work: Entering a New Era in Non-Clear Cell RCC Management Category: Online Events |
View Full Calendar
Announcements
Learn how to have your facility become a SRC/NAFC Center of Excellence In Continence Care for Women.
LUGPA groups will receive a discount on certification fees.
LUGPA members can login to access past content On Demand.